Today: 23 November 2025
Subscribe
Browse Category

Investment News News 22 October 2025 - 24 October 2025

Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz

Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz

Stock Performance: Clover Health stock has been exceptionally volatile in mid‑October 2025. On Oct. 21 it jumped ~8.7% intraday to ~$3.20 marketbeat.com (from $2.92 prior close), and on Oct. 24 it spiked another ~18%, trading near $3.79 (from $3.20 close on Oct. 23) reuters.com. According to Reuters data, that surge propelled CLOV close to its 52-week high (~$4.87) and far above its recent 50‑day moving average (around $2.82) marketbeat.com. The 200-day average (~$3.02) was also eclipsed, signaling strong upward momentum marketbeat.com. This rally has come on unusually heavy volume (15+ million shares traded on Oct. 24 vs. a 3‑month average
24 October 2025
 ·  ·  ·  ·  · 
The $350B Shake-Up: How AI Summaries Rewire Publisher Traffic

Alphabet Stock Skyrockets to Record High, Nears $3 Trillion on AI Boom & Earnings Hype

Key Facts – October 24, 2025 Alphabet Rallies to Near Record Highs on AI Momentum Google’s headquarters campus in Mountain View. Alphabet’s stock (GOOG) has been on a tear, reaching all-time highs as investors cheer the company’s AI strides and strong financial performance. Alphabet’s stock is soaring into uncharted territory as of late October 2025. Shares of the Google parent company traded around $260–261 on Friday, flirting with the highest levels in its history stocktwits.com. Earlier this week, Alphabet hit an intraday peak just above $257 – marking a new record – and its latest surge has propelled the company’s
24 October 2025
 ·  ·  ·  ·  · 
Picard Medical Stock Plummets 75% on Dilution Alert — What’s Driving the Crash?

Picard Medical Stock Plummets 75% on Dilution Alert — What’s Driving the Crash?

Stock Price & Recent Movement Picard Medical stock has been extremely volatile this month. After its Aug. 29 IPO at $4.00, PMI traded mostly under $10, but shot higher in mid-October. On Oct. 20 the stock closed around $11.60, then hit a new 52-week peak near $13.68 by Oct. 23 stockanalysis.com. However, on Oct. 24 trading opened sharply lower. By mid-day Oct. 24 the shares were about $3.30, erasing nearly all the prior week’s gains investing.com. Investing.com confirms that as of Oct. 24, 2025 PMI was trading at $3.27 with a previous close of $13.20 investing.com. This represents a collapse
24 October 2025
 ·  ·  ·  ·  · 
General Dynamics Stock Rockets to Record High on Blowout Q3 Results and Defense Windfall

General Dynamics Stock Rockets to Record High on Blowout Q3 Results and Defense Windfall

Blowout Q3 Results and Rising Orders General Dynamics (NYSE: GD) stunned investors on Oct. 24, 2025, with a blowout third-quarter report. The defense and aerospace giant said Q3 revenue was $12.91 billion – about 10.6% higher than a year ago – beating the ~$12.57 billion analysts expected benzinga.com. GAAP earnings per share came in at $3.88, well above the $3.69 consensus estimate benzinga.com benzinga.com. Operating income was $1.3 billion, and margins expanded by 20 basis points to 10.3%. Management highlighted exceptionally strong demand. Each of our four segments grew earnings and backlog in the quarter, reflecting solid execution coupled with growing demand,” CEO
24 October 2025
 ·  ·  ·  ·  · 
NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

Recent FDA Approval and Market Reaction NeurAxis’s Oct. 24, 2025 announcement of FDA 510(k) clearance for its PENFS device immediately grabbed market attention. The clearance authorizes use in adults (8 years and up) for functional abdominal pain associated with FD and nausea, a segment previously lacking any approved device treatment investing.com. Investing.com and other outlets confirm this milestone — noting it’s the first FDA clearance or approval” for an adult FD treatment investing.com. In pre-market trading on Oct. 24, NRXS shares jumped (around +4% in early quotes) on the news, reflecting relief that FDA evidence support (from pediatric studies) could
24 October 2025
 ·  ·  ·  ·  · 
Transocean Stock Skyrockets After Insider Buys Millions and Wins $243M Deepwater Contracts

Transocean Stock Skyrockets After Insider Buys Millions and Wins $243M Deepwater Contracts

Insider Buying and New Deals Transocean’s recent rally was ignited by concrete news. As noted, Frederik Mohn’s $12M stock purchase was a signal to the market ts2.tech. Shortly before that, the company announced the two deepwater drillship extensions described above. The Atlas (U.S. Gulf) was booked for 365 days at a firm dayrate, and the Mykonos (Brazil) for 30 days deepwater.com. These awards alone add ~$243M to backlog, which management reports at about $6.7B deepwater.com. In context, this year’s backlog has held up well (versus ~$7.2B at Q2’25) – reflecting ongoing demand for modern deepwater rigs. The new contracts came
24 October 2025
 ·  ·  ·  · 
AI Stock Boom or Bubble? Tech Rally Soars as Experts Warn of Risk

Supermicro Stock Plunges 8% as AI Server Boom Hits a Snag – What’s Next for SMCI?

Shares Slump on a Surprise Revenue Warning Supermicro (NASDAQ: SMCI) shares tumbled on Thursday, October 23, after the server maker issued a surprise revenue warning for its current quarter. The company revealed that first-quarter fiscal 2026 revenue would come in around $5 billion, well below its earlier $6–7 billion outlook reuters.com. The announcement – which cited design win upgrades” and customer delivery schedule shifts for large AI projects – immediately spooked investors. SMCI stock plunged roughly 7–8% on the news, falling from about $52 to $48 by day’s end reuters.com investing.com. That erased roughly a month’s worth of gains in a single
23 October 2025
 ·  ·  ·  ·  · 
Garrett Motion Stock Skyrockets on Turbocharged Q3 Beat and EV Tech Push

Garrett Motion Stock Skyrockets on Turbocharged Q3 Beat and EV Tech Push

Key Facts: GTX stock closed near $12.50 on Oct 22, 2025 and then surged about 20% to roughly $15 on Oct 23, hitting a 52-week high reuters.com stockanalysis.com. The jump followed a 9% jump in Q3 sales ($902M vs. $826M a year ago) and EPS of $0.38 (vs. $0.32 expected) investing.com. Garrett raised its 2025 outlook, approved a 33% dividend hike to $0.08/share, and repurchased $84M in stock investing.com. Analysts are largely bullish: consensus is a Strong Buy” with an average 12‑month target around $16–$17 nasdaq.com stockanalysis.com. Industry observers note Garrett’s focus on turbocharging and electrified boosting tech could keep
23 October 2025
 ·  ·  ·  ·  · 
Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last?

Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last?

SCNX Stock Soars on Arbli Launch News Scienture’s stock has been on a rollercoaster in late October amid excitement over Arbli’s rollout. The initial catalyst came on October 16, 2025, when the company announced Arbli™ was available through major wholesalers – making it the first FDA-approved liquid losartan on the market ts2.tech. That morning, SCNX shares surged over 30% from the prior day’s $0.72 close, even hitting an intraday high around $1.12 before profit-taking set in ts2.tech. By mid-day Oct. 16, Reuters reported the stock had pulled back near $0.71 ts2.tech, indicating traders sold into the early pop. Still, the
23 October 2025
 ·  ·  ·  · 
Volvo Cars’ Stock Skyrockets 40% After Surprise Profit Surge – Biggest Jump Since IPO

Volvo Cars’ Stock Skyrockets 40% After Surprise Profit Surge – Biggest Jump Since IPO

Volvo’s Cost-Cutting Turnaround Delivers a Big Win Volvo Cars delivered a stunning earnings surprise on October 23, posting third-quarter profits nearly four times higher than analysts expected reuters.com. This sharp turnaround comes after months of belt-tightening under CEO Håkan Samuelsson, who returned to lead the Swedish automaker earlier this year. In just half a year, Samuelsson has executed sweeping cost-cut measures – axing 3,000 jobs, freezing new investments, and even withdrawing profit guidance – to combat faltering” margins and an industry slowdown reuters.com. Those tough measures worked faster than anyone anticipated. What we’re now seeing is really, wow okay, this
23 October 2025
 ·  ·  ·  · 
Tesla Stock Soars on Record Q3 Deliveries, Profit Miss Raises Concerns

Tesla Stock Soars on Record Q3 Deliveries, Profit Miss Raises Concerns

Stock Performance & Market Context Tesla’s stock has been on a tear in October, but also volatile. It hit an intraday high near $453 on Oct. 6 (a 52-week peak) ts2.tech, then oscillated with market swings. By Oct. 21 TSLA closed around $442.60 ts2.tech. The stock jumped about 5% on Oct. 13 amid a broad tech rally, then eased 1–2% the next day as concerns over U.S.–China trade flared (Tesla is sensitive to China demand and tariffs) ts2.tech. Year-to-date TSLA is up roughly 80%, far outpacing the S&P 500’s ~17% gain ts2.tech ts2.tech. This strength reflects excitement over Tesla’s growth
23 October 2025
 ·  ·  ·  ·  · 
QuantumScape Rockets on Solid-State Battery Breakthrough – Investors Thrilled But Cautious

QuantumScape Rockets on Solid-State Battery Breakthrough – Investors Thrilled But Cautious

Solid-State Breakthrough and B1 Cell Shipments QuantumScape (NYSE: QS) develops solid-state lithium-metal batteries – a next-gen design using a thin ceramic separator and a lithium-metal anode instead of traditional graphite. This allows much higher energy density and faster charging (while improving safety) compared to conventional Li‑ion cells carboncredits.com. In practice, QS demonstrated its technology at this year’s IAA Mobility show: a Ducati V21L electric race bike (VW/Audi/PowerCo collaboration) ran on QS’s QSE‑5 cells and achieved an astonishing ~844 Wh/L of energy density and a 10%→80% charge in only about 12 minutes ts2.tech. This real‑world demo silenced some skeptics” and showed
22 October 2025
 ·  ·  ·  ·  · 
1 … 15 16 17 18 19 … 25
Go toTop